COVID 19, Depression
Conditions
Keywords
Confinement, Depression, Post traumatic stress, Adults
Brief summary
Quarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms. From March 17th, 2020 to May 11th 2002, the French government has implemented national containment measures due to the Covid-19 epidemic. Although there are data on the psychological impact and experience of quarantine measures in people who have been infected or suspected of being carriers of certain pathogens (e.g. Ebola), there are no data on such impact in the French population and quarantines lasting longer than 21 days. Investigators therefore propose to conduct a human and social sciences study in order to better understand the current situation
Detailed description
The main objective is to describe the psychological state during confinement (and the impact of the confinement) in a sample of the French general population. Secondary objectives : * to assess the evolution of psychological health between the period of confinement and post-confinement. * to identify clinical factors modulating psychological state during confinement It is expected to highlight : * a link between the intensity of anxiety symptoms and the number/quality of social contacts * a reduction of anxiety and depression symptoms in the post-confinement period. * higher consumption of drugs during the confinement period Self-questionnaires (Google form format) are sent by mailing lists or social networks to participants in order to complete the assessment of psychological state. A unique identifier is sent in a separate email. These assessments are performed at least once during the confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3 and 6 months after the lifting of the confinement because of the risk of developing anxiodepressive symptoms, in particular post-traumatic stressors.
Interventions
OTHERSlef questionnaires fulfilment
Questionnaires to assess the psychological impact of confinement and its evolution over 6 months
Sponsors
University Hospital, Montpellier
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
\- age\> 18
Exclusion criteria
\- protective measure (curatorship, guardianship)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Depressive Symptomatology | during confinement | depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -\> min : 0 max : 27) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Depressive Symptomatology | post-confinement : 15 days, 3 months, 6 months | depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -\> min : 0 max : 27) |
Other
| Measure | Time frame | Description |
|---|---|---|
| sleep | during confinement | quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -\> min : 0 max : 28) |
| anxiety | during confinement | anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -\> min : 0 max : 21) |
| psychological pain | post-confinement (15 days, 3 months, 6 months) | psychological pain : likert scale (higher score, more psychological pain-\> min : 0 max : 10) |
| physical pain | during confinement | psychological pain : likert scale (higher score, more psychological pain-\> min : 0 max : 10) |
| anger | during confinement | staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -\> min : 0 max : 50) |
| orientation of life | confinement | Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --\> min : 0 max : 24 |
| Use of psychotropic drugs | during confinement | Number of patients declaring an increase of psychotropic drug use |
| Tobacco consumption | during confinement | Number of patients declaring an increase of tobacco consumption |
| alcohol consumption | post-confinement (15 days, 3 months, 6 months) | Number of patients declaring an increase of alcohol consumption |
| Illicit substances consumption | confinement | Number of patients declaring an increase of illicit substances consumption |
| Stressful Event Impact | during confinement | Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -\> min : 0 max : 45) ) |
| Psychological pain | during confinement | Psychological pain : likert scale (higher score, more psychological pain-\> min : 0 max : 10) |
Countries
France
Contacts
Primary ContactEmilie Olie, MD PhD
Outcome results
None listed